Regulated in development and DNA damage responses -1 (REDD1) protein contributes to insulin signaling pathway in adipocytes

PLoS One. 2012;7(12):e52154. doi: 10.1371/journal.pone.0052154. Epub 2012 Dec 18.

Abstract

REDD1 (Regulated in development and DNA damage response 1) is a hypoxia and stress response gene and is a negative regulator of mTORC1. Since mTORC1 is involved in the negative feedback loop of insulin signaling, we have studied the role of REDD1 on insulin signaling pathway and its regulation by insulin. In human and murine adipocytes, insulin transiently stimulates REDD1 expression through a MEK dependent pathway. In HEK-293 cells, expression of a constitutive active form of MEK stabilizes REDD1 and protects REDD1 from proteasomal degradation mediated by CUL4A-DDB1 ubiquitin ligase complex. In 3T3-L1 adipocytes, silencing of REDD1 with siRNA induces an increase of mTORC1 activity as well as an inhibition of insulin signaling pathway and lipogenesis. Rapamycin, a mTORC1 inhibitor, restores the insulin signaling after downregulation of REDD1 expression. This observation suggests that REDD1 positively regulates insulin signaling through the inhibition of mTORC1 activity. In conclusion, our results demonstrate that insulin increases REDD1 expression, and that REDD1 participates in the biological response to insulin.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 3T3-L1 Cells
  • Adipocytes / drug effects
  • Adipocytes / metabolism*
  • Animals
  • Enzyme Activation
  • HEK293 Cells
  • Humans
  • Insulin / metabolism*
  • Insulin / pharmacology
  • MAP Kinase Signaling System / drug effects
  • Mice
  • Proteasome Endopeptidase Complex / metabolism
  • Proteolysis
  • Signal Transduction* / drug effects
  • Transcription Factors / metabolism*

Substances

  • DDIT4 protein, human
  • Insulin
  • Transcription Factors
  • Proteasome Endopeptidase Complex

Grants and funding

This work was supported by INSERM, France, Société Francophone du Diabète, Agence Nationale de la Recherche (ANR-09-GENO-036), the Association for Research on Diabetes (Paris, France), the University of Nice-Sophia Antipolis, Region Provence- Alpes-Cote-d’Azur, Conseil Général des Alpes Maritimes. This work is part of the project “Hepatic and Adipose Tissue and Functions in the Metabolic Syndrome” (HEPADIP), which is supported by the European Commission as an integrated Project under the 6th Framework Program, Contract LSHM-CT-2005-018734. C.R. is a recipient of a fellowship from Ministère de la recherche et de l’éducation (2008–2011) and Société Francophone du Diabète (2011–2012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.